Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Themis Medicare Ltd - 530199 - Intimation Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Disclosure Of Related Party Transactions

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2019.
25-06-2019
Bigul

Themis Medicare Ltd - 530199 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report28/05/2019 3 Name of the Certifying Firm Shirish Shetye & Associates 4 Name of the Certifying Individual CS Shirsh Shetye 5Membership TypeFCS 6 Membership Number 1926 7 CP No. 825 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes
29-05-2019
Bigul

Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the copy of newspaper advertisement of the Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2019, published in The Times of India - (English Newspaper) and The Economic Times - Ahmedabad Gujarat (Gujarati Newspaper) on May 29, 2019 for your reference. This is for your information and record.
29-05-2019
Bigul

Themis Medicare Ltd - 530199 - Outcome of Board Meeting (AGM on August 27, 2019)

 Themis Medicare Ltd has informed BSE about Outcome of Board Meeting held on May 28, 2019.
28-05-2019
Bigul

Themis Medicare Ltd - 530199 - Standalone And Consolidated Financial Results For The Quarter And Year Ended 31St March, 2019

 The Board of Directors at its meeting held today, inter alia, considered and approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2019. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2019 is enclosed herewith. (Annexure I) As reported in the attached Financial Results, the figures of quarter ended March 31, 2019 and March 31, 2018 are the balancing figures between audited figures in respect of full financial year and published year-to-date figures upto the third quarter of the year ended March 31 , 2019 and March 31, 2018, respectively. We further state that M/s. R. P. Sardar & Co., Chartered Accountants, Statutory Auditors of the Company, have issued Audit Report with unmodified opinion on the Financial Results for the Quarter and year ended 31.03.2019. We have enclosed herewith the Declaration pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015(Annexure II)
28-05-2019
Bigul

Themis Medicare Ltd - 530199 - Outcome of Board Meeting

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2019. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2019 is enclosed herewith. (Annexure I) 2. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2019-20. 3. Confirmed the time, date and venue of the 49thAnnual General Meeting which will be held on Tuesday, 27th August, 2019 at the Registered Office of the Company. 4. Appointed Mr. Shirish Shetye of M/s. Shirish Shetye & Associates, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 49thAnnual General Meeting. As reported in the attached Financial Results, the figures of quarter ended March 31, 2019 and March 31, 2018 are the balancing figures between audited figures in respect of full financial year and published year-to-date figures upto the third quarter of the year ended March 31 , 2019 and March 31, 2018, respectively. We further state that M/s. R. P. Sardar & Co., Chartered Accountants, Statutory Auditors of the Company, have issued Audit Report with unmodified opinion on the Financial Results for the Quarter and year ended 31.03.2019. We have enclosed herewith the Declaration pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/56/2016 dated May 27, 2016. (Annexure II)
28-05-2019
Bigul

Annual report for Themis Medicare Ltd. for FY-2019
28-05-2019
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the copy of newspaper advertisement of Notice of the Meeting of the Board of Directors of Themis Medicare Limited scheduled to be held on Tuesday, May 28, 2019, published in The Times of India - (English Newspaper) and The Economic Times - Ahmedabad Gujarat (Gujarati Newspaper) on May 21, 2019 for your reference
22-05-2019
Bigul

Themis Medicare Ltd - 530199 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2019.

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve To consider and approve Annual Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2019 alongwith Auditors Report; and To consider other general matters.
16-05-2019
Bigul

Themis Medicare Ltd - 530199 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayTHEMIS MEDICARE LTD. 2CININE083B01016 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 2 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sangameshwar Iyer Designation: Company Secretary and Compliance Officer EmailId: themis@themismedicare.com Name of the Chief Financial Officer: Tushar J Dalal Designation: Chief Financial Officer EmailId: themis@themismedicare.com Date: 30/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
30-04-2019
Next Page
Close

Let's Open Free Demat Account